Andrew Rosenthal is a digital health product leader with a strong entrepreneurial spirit and a focus on building platform products from complex data and systems. With an MBA from Harvard Business School and a BA in Health and Societies from the University of Pennsylvania, Rosenthal has held multiple advisory positions in companies like Superconductive and The Graduate Syndicate, and senior leadership positions at eHealth, Inc., Jawbone, and Amino. He has also formerly served as interim Chief Strategy Officer & Head of Product, R&D at PAI Health, and as Chief Strategy Officer at Massive Health (acquired by Jawbone). Rosenthal's collaborative approach to leading through ambiguity and applying business impact to design and narrative has been demonstrated throughout his career.